IRLAB: Invitation to the interim report for Q1 2025 presentation and webcast

Gothenburg, Sweden, May 6, 2025 – IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel treatments for Parkinson’s disease, today announced that the company will hold a presentation in conjunction with the publication of the interim report for the period January – March 2025. The interim report will be published on Wednesday, May 7 at 07:00 CEST.

The presentation will be held on May 7, 2025, at 11:30 CEST via digital webcast. Kristina Torfgård, CEO, Nicholas Waters, EVP and Head of R&D, and Viktor Siewertz, CFO, will comment the interim report. The presentation will be held in English and will be followed by a Q&A session.

Follow the webcast online: https://www.youtube.com/watch?v=RWNlkYDnHWg

The interim report and the presentation will be available on www.irlab.se, and the recorded version of the presentation will be available shortly afterward.

Datum 2025-05-06, kl 07:00
Källa MFN
Hej Serverägare! Har du problem med troll och spam? Nu finns möjligheten att sätta en liten avgift, t.ex. 20kr, på discord invites och därmed stoppa många återkommande troll samtidigt som du tjänar lite pengar. Kolla in Invite Paywall.